Skip to main content
Clinical Trials/NCT04557709
NCT04557709
Withdrawn
N/A

A Descriptive Study of Major Complications in Oncology Patients With Neutropenic Fever Potentially Eligible for a Hospital at Home Program

M.D. Anderson Cancer Center0 sites126 target enrollmentJuly 13, 2020

Overview

Phase
N/A
Intervention
Not specified
Conditions
Hematopoietic and Lymphoid Cell Neoplasm
Sponsor
M.D. Anderson Cancer Center
Enrollment
126
Primary Endpoint
Percentage of patients who experience major complications that require escalated care
Status
Withdrawn
Last Updated
8 months ago

Overview

Brief Summary

This study investigates the major complication rate in cancer patients potentially eligible for a hospital at home program for management of neutropenic fever. "Hospital at Home" is a home care program that provides acute, inpatient care in a patient's home in place of a traditional hospital stay. Learning more about the characteristics of potentially eligible patients, including reasons for inpatient admission, rates of major complications, and situations or treatments that would be difficult to deliver in an at home setting may help to inform future program development.

Detailed Description

PRIMARY OBJECTIVE: I. Estimate the major complication rate among patients potentially eligible for a hospital at home program for management of neutropenic fever. SECONDARY OBJECTIVES: I. Describe the demographic and clinical characteristics of patients potentially eligible for admission to a hospital at home program for management of neutropenic fever. II. Describe situations or treatments experienced by potentially eligible patients admitted for neutropenic fever that would be difficult to accomplish in a hypothetical hospital at home program (e.g., blood transfusions, echocardiograms, computed tomography \[CT\] scans). OUTLINE: Patients' medical charts are reviewed.

Registry
clinicaltrials.gov
Start Date
July 13, 2020
End Date
November 18, 2024
Last Updated
8 months ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Admitted to MD Anderson Cancer Center through the Emergency Center with a diagnosis of neutropenic fever between 1/1/2019 and 12/31/2019
  • Be at low risk for major complications as defined by a Multinational Association for Supportive Care in Cancer (MASCC) score \< 21

Exclusion Criteria

  • Reside in a nursing home
  • Homelessness
  • Hospice enrollment
  • A secondary reason for admission to the hospital or high risk clinical feature not captured in the MASCC score that places them at high risk for major complications in a hospital at home program

Outcomes

Primary Outcomes

Percentage of patients who experience major complications that require escalated care

Time Frame: 1 month

Percentages will be presented with exact binomial 95% confidence interval. Also, will identify significant predictors of major complications (yes or no) using univariable logistic regression.

Secondary Outcomes

  • Patient demographic, clinical, and psychosocial features(1 month)
  • Situations or treatments experienced by potentially eligible patients admitted for neutropenic fever that would be difficult to accomplish in a hypothetical hospital at home (HaH) program(1 month)

Similar Trials